Brief: Wave Life Sciences On Track To Initiate Clinical Trial Of Its INHBE Program In Q1 2025
23/04/2024 13:55
April 23 (Reuters) - WAVE Life Sciences Ltd WVE.O :
* WAVE LIFE SCIENCES LTD: WAVE IS ON TRACK TO INITIATE A
CLINICAL
TRIAL OF ITS WHOLLY OWNED INHBE PROGRAM FOR OBESITY IN 1Q 2025
Source text for Eikon: ID:nGNX9BsvpX
Further company coverage: WVE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Wave Life Sciences
See all newsWave Life Sciences Ltd Reports Results For The Quarter Ended June 30: Earnings Summary
Wave Life Sciences Ltd Expected To Post A Loss Of 31 Cents A Share: Earnings Preview
Wave Life Sciences Q1 revenue jumps, beats analyst estimates
Brief: Wave Life Sciences Announces Hearing On Proposed Redomiciliation To The United States
Brief: Wave Life Sciences Announces Proposed Redomiciliation To The United States